US Medicare should use cost-effectiveness more in decision-making
This article was originally published in Clinica
Executive Summary
Medicare officials could play an important role in advancing the field of cost effectiveness, an influential advisory group told Congress yesterday. Current studies vary in the methods used to compare the relative costs of one medical product to another, the Medicare Payment Advisory Commission (MedPAC) pointed out.